Taking into account the enhanced glutamate present in MNs in ALS, the A2aRs is considered as a potential neuroprotective therapeutic agent to ameliorate glutamate induced excitotoxicity in ALS, reinforcing the significance of TrkB transactivation. This evidence concerns the gene NTRK2 and amyotrophic lateral sclerosis.